1. The market is expected to reach a value of approximately $43 billion by 2019.
2. The market is estimated to grow at a compound annual growth rate of 7 percent from 2014 to 2019.
3. The major drivers for the market growth are an aging population, increase in cancer, diabetes and obesity patients as well as a rise in patient’s preference for minimal invasive surgeries.
4. However, the shortage of qualified endoscopic technicians, the high cost of initial investment, contamination risk and patient safety of endoscopic procedures are restrictions to market growth.
5. North America accounts for the largest market share, but there is a growing demand in emerging countries as well, such as India and China.
6. Some of the leading players in the market include Johnson and Johnson, Olympus and Covidien.
More articles on GI/endoscopy:
Gastroenterology special issue: “You are what you eat”
Boston Scientific sales hit $1.77 billion in Q1: 5 things to know
GI physician leader to know: Dr. Lawrence Kosinski of Illinois Gastroenterology Group
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
